1. Introduction {#sec1-ijerph-17-02439}
===============

Type 2 diabetes (T2D) is a severe chronic non-communicable disease concerning public health in China \[[@B1-ijerph-17-02439]\]. It may cause multiple organ complications such as diabetic retinopathy, diabetic nephropathy, and peripheral neuropathy, which has become a burden not only for individual physiology and psychology but also for allocation of health resources \[[@B2-ijerph-17-02439]\]. The pathogenesis of T2D is complicated, although lifestyle is a great contributor to the T2D epidemic, genetic determinants can also affect the T2D susceptibility \[[@B3-ijerph-17-02439]\]. Individuals carrying risk alleles predisposed to T2D are mediated by insulin resistance or abnormal insulin secretion \[[@B4-ijerph-17-02439]\]. Insulin resistance \[[@B5-ijerph-17-02439]\] is one critical process to the development of T2D, which means the function of pancreatic β-cells is commonly normal and insulin secretion is sufficient, but the insulin receptors are insensitive to insulin levels and the ability to stimulate glucose utilization is decreasing, or impairments in insulin signal transduction, resulting in a compensatory hyperinsulinemia \[[@B6-ijerph-17-02439]\]. Besides, insulin resistance is ordinarily related to obesity or other metabolic syndromes \[[@B7-ijerph-17-02439]\].

Insulin release decrease is another mechanism of T2D when pancreatic β-cells are impaired, and individuals are unable to utilize glucose which will cause high postprandial blood glucose. A majority of variants have been identified to associate with β-cell dysfunction \[[@B8-ijerph-17-02439]\], but evidence suggests that Asians might be more susceptible to insulin resistance than Europeans \[[@B9-ijerph-17-02439]\]. Genome-wide association studies (GWAS) for T2D have been widely carried out in different racial types, with the exception of T2D-associated genes, obesity-associated and birth weight-associated genes have also been found to relate to T2D, but results were inconsistent. For example, loci rs13266634 in gene SLC30A8 was associated with T2D in Russian and the Danish populations \[[@B10-ijerph-17-02439],[@B11-ijerph-17-02439]\], while the link disappeared in African populations \[[@B12-ijerph-17-02439]\]. A common obesity-associated gene, FTO, has been confirmed to have an association with T2D in different countries, and several gene loci were associated with insulin resistance such as rs9939609 and rs1558902 \[[@B13-ijerph-17-02439],[@B14-ijerph-17-02439]\]. Birth weight-associated loci rs6931514 in gene CDKAL1 was associated with reduced insulin secretion in Europeans \[[@B15-ijerph-17-02439]\], which suggested that the genetic variation was affected differently among races and geographic areas \[[@B2-ijerph-17-02439]\]. Insulin resistance and insulin release were assessed by homeostasis model assessment (HOMA) in multiple studies based on fasting plasma glucose (FPG) and fasting serum insulin (FSIN) \[[@B4-ijerph-17-02439]\]. Thus, our aim was to replicate the relationship that has been confirmed in other ethnic groups, further, to explore novel loci that have never been clearly associated with T2D-related quantitative traits in the Chinese population, providing the pathogenesis of T2D.

2. Materials and Methods {#sec2-ijerph-17-02439}
========================

2.1. Study Subjects {#sec2dot1-ijerph-17-02439}
-------------------

The data were from the 2010--2012 China National Nutrition and Health Surveillance (CNNHS). The CNNHS was a nationally representative cross-sectional surveillance conducted by the National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention (NINH, China CDC), which covered 31 provinces, autonomous regions, and municipalities (except for Taiwan, Hong Kong, and Macao). Cluster random sampling with multi-stage stratification proportional to population size sampling design was used in recruiting subjects \[[@B16-ijerph-17-02439]\]. For the present study, subjects born in 1960, 1961, and 1963 were included, and those with a low call rate of variants (\<50%), unqualified blood samples, failed DNA extraction, abnormal gene detection results, incomplete basic information, and those with T2D who took control measures were excluded. Finally, a total of 1654 subjects were included in the present study. The protocol was approved by the Ethics Committee of NINH, China CDC (No.2013-010). Written informed consent was obtained from each subject.

2.2. Assessment and Definition of Insulin Resistance and Impaired Insulin Release {#sec2dot2-ijerph-17-02439}
---------------------------------------------------------------------------------

Fasting venous blood samples were taken from each subject in the morning. Fasting plasma glucose (FPG) was measured using the glucose oxidize enzymatic method within 3 hours of blood collection. Fasting serum insulin (FSIN) was measured by radioimmunoassay. Insulin resistance and impaired insulin release were assessed by homeostasis model assessment of insulin resistance (HOMA-IR), homeostasis model assessment of beta cell function (HOMA-β), respectively, which was calculated by the following equation:

HOMA-IR = FPG × FSIN/22.5, HOMA-β = FSIN × 20/(FPG − 3.5) (with serum insulin in mU/L and plasma glucose in mmol/L) \[[@B4-ijerph-17-02439]\].

Insulin resistance was defined by exceeding the top quartile of HOMA-IR index value and impaired insulin release was defined under bottom quartile of HOMA-β index value in non-diabetic individuals \[[@B17-ijerph-17-02439]\].

2.3. Genotyping and SNP Selection {#sec2dot3-ijerph-17-02439}
---------------------------------

The genotype of 81 diabetes-related single nucleotide polymorphisms (SNPs) were detected by Mass ARRAY (Agena, San Diego, CA, USA). SNPs' exclusion criteria: (1) call rates \<80%; (2) deviating from Hardy--Weinberg equilibrium *p* \< 0.001 ([Table S1](#app1-ijerph-17-02439){ref-type="app"}); (3) a minor allele frequency (MAF) of each SNP \<5%. Finally, a total of 64 variants were involved in the present study, of which 22 SNPs had previously confirmed association with insulin resistance ([Table S2](#app1-ijerph-17-02439){ref-type="app"}), 27 loci were associated with insulin release ([Table S3](#app1-ijerph-17-02439){ref-type="app"}). The association of the left 15 loci with T2D had been indicated, however, whether these SNPs related to insulin release or insulin resistance were still unclear.

2.4. Demographic Characteristic, Physical Activity and Dietary Measurement {#sec2dot4-ijerph-17-02439}
--------------------------------------------------------------------------

Questionnaires were used to obtain information. Self-reported educational levels were categorized into three levels: primary school or lower, junior middle school, senior high school or above. According to the per capita annual income of urban and rural households in 2011, the family economic level was divided into three levels: low (\<20,000 RMB), middle (20,000--40,000 RMB) and high (\>40,000 RMB). Smoking was coded as "yes" if smoking during the past 30 days. Drinking alcohol was coded as "yes" if drinking any type of alcohol during the past 12 months. Physical exercise was coded as "yes" if attending leisure time physical exercise during the past 3 months. The sedentary time was defined as time spent sitting or lying in leisure time.

Height, weight, and waist circumference was measured by trained investigators under standard operation procedure. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared (kg/m^2^).

The dietary intake was collected by food frequency questionnaire (FFQ) and three consecutive (two weekdays and one weekend day) 24-h recalls which were described elsewhere \[[@B16-ijerph-17-02439]\]. The whole cereal and beans intake level was divided into low (less than 50 g per day), medium (more than or equal to 50 g and less than or equal to 150 g per day), and high (more than 150 g per day). Livestock and poultry intake level was divided into low (less than 40 g per day), medium (more than or equal to 40 g and less than or equal to 75 g per day), and high (more than 75 g per day) based on the recommendations of Dietary Guideline for Chinese Residents (2016) \[[@B18-ijerph-17-02439]\].

2.5. Statistical Analysis {#sec2dot5-ijerph-17-02439}
-------------------------

Data analyses were conducted using statistical analysis system (SAS) 9.4 software (SAS Institute, Cary, NC, USA). A Hardy--Weinberg equilibrium test was performed for each SNP of non-diabetic individuals by chi-square test \[[@B19-ijerph-17-02439]\]. Continuous variables were expressed as mean ± SD, and categorical variables were presented as frequency and percentage. T-tests and chi-square tests were performed for comparisons of continuous and categorical variables between males and females, respectively. A logistic regression model was utilized to validate the association of individual SNPs with T2D-related quantitative traits corrected for confounders, including gender, economical status, education levels, BMI, waist circumference, sedentary time, exercise, whole cereal and beans intake levels, livestock and poultry intake levels, drinking, and smoking. Two-tailed *p* \< 0.05 regarded as statistical significance.

3. Results {#sec3-ijerph-17-02439}
==========

3.1. Basic Characteristics of Study Subjects {#sec3dot1-ijerph-17-02439}
--------------------------------------------

Basic characteristics are shown in [Table 1](#ijerph-17-02439-t001){ref-type="table"}. The age of 1654 subjects (male 39.1%, female 60.9%) was 49.9 ± 1.5 years. The rate of impaired insulin release in males was 32.6%, which was higher than that in females (*p* \< 0.05). There were no significant differences between male and female in the rate of insulin resistance. There were significant differences between males and females in education level, smoking, drinking, whole cereal and beans intake levels, livestock and poultry intake levels, BMI, waist circumference, and exercise.

3.2. Association between Individual SNP and Insulin Resistance {#sec3dot2-ijerph-17-02439}
--------------------------------------------------------------

As shown in [Table 2](#ijerph-17-02439-t002){ref-type="table"} and [Figure 1](#ijerph-17-02439-f001){ref-type="fig"}, three SNPs were associated with increased insulin resistance risk with adjusting for covariates, including 5q11.2-rs4432842 (OR = 1.23, 95% CI: 1.04--1.45), RASGRP1-rs7403531 (OR = 1.35, 95% CI: 1.13--1.62), SEC16B-rs574367 (OR = 1.34, 95% CI: 1.07--1.67). Rs11030104 in gene BDNF (OR = 1.18, 95% CI: 1.01--1.39) with insulin resistance was found, which disappeared after adjusting for covariates (*p* = 0.184).

MAEA-rs6815464 was associated with decreased insulin resistance with correction for covariates, the OR was 0.84 (95% CI: 0.71--1.00). CENTD2-rs1552224 had an association with decreased insulin resistance (OR = 0.75, 95% CI: 0.58--0.98), while the link disappeared after controlling for covariates (*p* = 0.063).

3.3. Association between Individual SNP and Impaired Insulin Release {#sec3dot3-ijerph-17-02439}
--------------------------------------------------------------------

Association of CENTD2-rs1552224 (OR = 1.47, 95% CI: 1.09--1.99), TSPAN8-rs7961581 (OR = 1.25, 95% CI: 1.03--1.51) and rs516946 (OR = 1.39, 95% CI: 1.07--1.81) with increased impaired insulin release were significant without or with adjustment for covariates. (See [Table 2](#ijerph-17-02439-t002){ref-type="table"} and [Figure 2](#ijerph-17-02439-f002){ref-type="fig"})

4. Discussion {#sec4-ijerph-17-02439}
=============

Among the 64 susceptible loci we examined, RASGRP1-rs7403531, ANK1-rs516946, and SEC16B-rs574367 had associations with insulin resistance. HHEX-rs5015480, CENTD2-rs1552224, and TSPAN8-rs7961581 were associated with impaired insulin release in the current Chinese population.

Our study has replicated the association of rs7403531 with insulin resistance, which was consistent with a previous study which reported that rs7403531 had been associated with T2D and higher insulin in Chinese Hans \[[@B20-ijerph-17-02439]\]. However, Sakai et al. \[[@B21-ijerph-17-02439]\] found no significant association of rs7403531 with T2D. Insulin sensitivity is one of the predictors of diabetes \[[@B22-ijerph-17-02439]\], therefore, these findings indicated that carriers of rs7403531 may be predisposed to T2D by decreasing insulin sensitivity. Additionally, rs7403531 had the same OR for insulin resistance after correcting for BMI, suggesting its association with insulin resistance might not be mediated through obesity.

Most studies were conducted to explore the association of rs574367 with BMI, but seldom T2D. The G allele of SEC16B-rs574367 increased the risk for obesity in different ethnic populations \[[@B23-ijerph-17-02439]\]. SEC16B-rs574367 could affect the synthesis and transcription of lipase, thus inhibiting the decomposition of fat, leading to the occurrence of obesity \[[@B24-ijerph-17-02439]\]. Several obesity-associated loci including rs574367 constructed a BMI gene risk score (BMI-GRS), which had an enhanced effect on log (HOMA2-IR) in the age- and sex-adjusted model among Chinese adults \[[@B25-ijerph-17-02439]\]. Our study found rs574367 had the same risk for increased HOMA-IR. Further study should be conducted to confirm the relationship.

MAEA-rs6815464 (macrophage erythroblast attacher) was reported as a T2D risk variant in Asians \[[@B26-ijerph-17-02439],[@B27-ijerph-17-02439]\]. In the Chinese population, no significant association was observed with insulin resistance or insulin release, measured by fasting-based homeostasis model assessment \[[@B28-ijerph-17-02439]\]. A genome-wide association study identified MAEA gene altered T2D risk through insulin secretion \[[@B29-ijerph-17-02439]\]. However, in our study, rs6815464 had an association with decreased insulin resistance after adjustment for confounding factors. Therefore, further functional characterization study is required to elucidate its role in the pathogenesis of T2D.

A Mendelian randomization study has shown that lowered birthweight 5q11.2-rs4432842 could increase susceptibility to T2D \[[@B30-ijerph-17-02439]\]. However, it remains unclear what its role in the pathogenesis of T2D is. Our study found 5q11.2-rs4432842 was associated with increased risk of insulin resistance.

The association of rs516946 with T2D has been confirmed by previous studies \[[@B31-ijerph-17-02439],[@B32-ijerph-17-02439]\]. ANK1-rs516946 was associated with impaired insulin release by decreasing insulinogenic and disposition indexes in a Danish cohort study \[[@B32-ijerph-17-02439]\]. The risk C allele of rs516946 with a larger waist circumference was found in a Han Chinese population \[[@B31-ijerph-17-02439]\]. After adjusting for waist circumference, the risk C allele of ANK1-rs516946 was associated with increased impaired insulin release in our study.

CENTD2-rs1552224 could increase the risk of T2D through reducing insulin secretion \[[@B11-ijerph-17-02439]\]. CENTD2-rs1552224 associated with decreased glucose-stimulated insulin release, which increased 30-min plasma glucose values by 2.0% and reduced insulin release 30 min after an oral glucose load by 4.2% \[[@B33-ijerph-17-02439]\]. CENTD2-rs1552224 increased the risk of impaired insulin release after correction for covariates in our study.

TSPAN8-rs7961581 increased the risk of T2D in a previous study in Han Chinese \[[@B34-ijerph-17-02439]\]. A study in Denmark confirmed that the C allele of TSPAN8-rs7961581 associated with decreased levels of corrected insulin response, of AUC-insulin/AUC-glucose ratio, and of the insulinogenic index \[[@B35-ijerph-17-02439]\]. Our study has replicated the association of TSPAN8-rs7961581 with T2D, TSPAN8-rs7961581 increased the risk of impaired insulin release by 25%.

The present study had some limitations. Firstly, the method of HOMA was not the golden standard to assess insulin resistance and impaired insulin release. The standard intravenous methods (euglycemic insulin clamp technique) and comprehensive indices should be used in the Chinese population to validate the relationship in future studies. Secondly, the participants in the present study were about 50 years old and too young to get enough cases of T2D. The small numbers may partly explain why no significant associations of some SNPs with the risk of quantitative traits of T2D were found.

5. Conclusions {#sec5-ijerph-17-02439}
==============

In summary, we have replicated the association of seven SNPs and quantitative traits of T2D among the Chinese population, of which 5q11.2-rs4432842, RASGRP1-rs7403531, and SEC16B-rs574367 were associated with increased insulin resistance, MAEA-rs6815464 was associated with decreased insulin resistance, and ANK1- rs516946, CENTD2-rs1552224, and TSPAN8-rs7961581 were associated with increased impaired insulin release. Our results would provide insight into the pathogenesis of individual SNP and T2D.

We would like to thank all the participants who took part in this study and the staff of 31 provinces at the 2010--2012 China Nutrition and Health Surveillance.

The following are available online at <https://www.mdpi.com/1660-4601/17/7/2439/s1>, Table S1: Hardy--Weinberg equilibrium test of T2D-associated loci, Table S2: Overview of investigated genetic variants associated with insulin resistance, Table S3: Overview of investigated genetic variants associated with insulin release.
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###### 

Basic characteristics of 1654 subjects.

  Characteristics                            Total          Male          Female         *p* Value
  ------------------------------------------ -------------- ------------- -------------- -----------
  Total                                      1654           647 (39.1%)   1007 (60.9%)   
  Age (year)                                 49.9 ± 1.5     49.9±1.5      49.9 ± 1.5     0.9347
  **Insulin resistance**                                                                 0.0950
  No                                         1189 (71.9%)   480 (74.2%)   709 (70.4%)    
  Yes                                        465 (28.1%)    167 (25.8%)   298 (29.6%)    
  **Impaired insulin release**                                                           0.0050
  No                                         1179 (71.3%)   436 (67.4%)   743 (73.8%)    
  Yes                                        475 (28.7%)    211 (32.6%)   264 (26.2%)    
  **Education level**                                                                    \<0.0001
  Illiterate or primary school               563 (34%)      140 (21.6%)   423 (42.0%)    
  Middle school                              723 (43.7%)    327 (50.5%)   396 (39.3%)    
  Senior school                              368 (22.2%)    180 (27.8%)   188 (18.7%)    
  **Economic status**                                                                    0.7453
  Low                                        839 (52.7%)    324 (52.1%)   515 (53.1%)    
  Middle                                     633 (39.8%)    254 (40.8%)   379 (39.1%)    
  High                                       119 (7.5%)     44 (7.1%)     75 (7.7%)      
  **Smoking**                                                                            \<0.0001
  No                                         1164 (70.5%)   204 (31.6%)   960 (95.4%)    
  Yes                                        487 (29.5%)    441 (68.4%)   46 (4.6%)      
  **Drinking**                                                                           \<0.0001
  Yes                                        1121 (67.9%)   250 (38.7%)   871 (86.6%)    
  No                                         531 (32.1%)    396 (61.3%)   135 (13.4%)    
  **Whole cereal and beans intake levels**                                               0.0171
  Low                                        1080 (86.5%)   425 (88%)     655 (85.5%)    
  Medium                                     133 (10.6%)    39 (8.1%)     94 (12.3%)     
  High                                       36 (2.9%)      19 (3.9%)     17 (2.2%)      
  **Livestock and poultry intake levels**                                                0.0003
  Low                                        517 (41.4%)    184 (38.1%)   333 (43.5%)    
  Medium                                     284 (22.7%)    93 (19.3%)    191 (24.9%)    
  High                                       448 (35.9%)    206 (42.7%)   242 (31.6%)    
  **BMI (kg/m^2^)**                          24.3 ± 3.4     24.0 ± 3.4    24.5 ± 3.4     0.002
  **Waist circumference (cm)**               82.2 ± 10.0    83.7 ± 10.4   81.3 ± 9.6     \<0.0001
  **Exercise**                                                                           0.0409
  No                                         1500 (91.4%)   600 (93.2%)   900 (90.3%)    
  Yes                                        141 (8.6%)     44 (6.8%)     97 (9.7%)      
  **Sedentary time (h/d)**                   2.7 ± 1.5      2.6 ± 1.4     2.7 ± 1.6      0.6235

Continuous variables were presented as mean ± SD, and categories variables were presented as N (%).
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###### 

Association between each SNP and quantitative traits of T2D.

  Identified Association to   Loci         Chr   Reported Gene    Risk/Other Allele   Insulin Resistance   Impaired Insulin Release                                                                         
  --------------------------- ------------ ----- ---------------- ------------------- -------------------- -------------------------- ----------------- ------- ----------------- ------- ----------------- -------
  T2D                         rs340874     1     PROX1            C/T                 0.97(0.83,1.14)      0.718                      0.96(0.81,1.13)   0.595   0.89(0.76,1.04)   0.137   0.90(0.76,1.05)   0.187
                              rs243021     2     BCL11A           A/G                 1.08(0.92,1.27)      0.362                      1.07(0.89,1.27)   0.486   0.94(0.80,1.10)   0.436   0.94(0.80,1.11)   0.483
                              rs2943641    2     IRS1             C/T                 1.20(0.89,1.62)      0.226                      1.26(0.92,1.73)   0.157   1.00(0.75,1.32)   0.985   0.98(0.74,1.31)   0.911
                              rs3923113    2     GRB14            A/C                 1.03(0.83,1.30)      0.770                      1.02(0.80,1.30)   0.852   1.16(0.92,1.46)   0.210   1.15(0.91,1.45)   0.247
                              rs7593730    2     RBMS1, ITGB6     C/T                 1.08(0.87,1.33)      0.509                      1.08(0.86,1.35)   0.532   0.91(0.74,1.12)   0.375   0.91(0.74,1.13)   0.399
                              rs780094     2     GCKR             C/T                 1.09(0.93,1.28)      0.284                      1.10(0.93,1.30)   0.293   1.00(0.85,1.17)   0.964   0.97(0.83,1.14)   0.726
                              rs1470579    3     IGF2BP2          C/A                 0.98(0.82,1.18)      0.854                      1.04(0.86,1.25)   0.716   1.04(0.87,1.24)   0.646   1.04(0.86,1.24)   0.708
                              rs16861329   3     ST6GAL1          T/C                 0.84(0.70,1.02)      0.081                      0.89(0.72,1.09)   0.246   0.86(0.71,1.04)   0.118   0.85(0.70,1.03)   0.103
                              rs4607103    3     ADAMTS9          C/T                 1.13(0.97,1.33)      0.123                      1.15(0.97,1.37)   0.099   0.87(0.74,1.01)   0.067   0.87(0.74,1.02)   0.083
                              rs4858889    3     SCAP             A/G                 1.01(0.81,1.26)      0.908                      1.07(0.84,1.35)   0.587   0.93(0.75,1.16)   0.539   0.90(0.72,1.13)   0.358
                              rs7612463    3     UBE2E2           C/A                 0.89(0.73,1.07)      0.205                      0.86(0.70,1.05)   0.142   1.04(0.86,1.25)   0.723   1.06(0.87,1.29)   0.561
                              rs831571     3     PSMD6            C/T                 1.10(0.93,1.29)      0.256                      1.11(0.93,1.32)   0.262   1.02(0.87,1.20)   0.775   1.01(0.85,1.19)   0.956
                              rs6815464    4     MAEA             C/G                 0.85(0.73,1.00)      0.053                      0.84(0.71,1.00)   0.044   1.12(0.96,1.32)   0.153   1.15(0.98,1.35)   0.098
                              rs459193     5     ANKRD55          G/A                 1.02(0.88,1.19)      0.780                      1.07(0.91,1.26)   0.434   1.02(0.87,1.18)   0.854   1.01(0.87,1.19)   0.865
                              rs10946398   6     CDKAL1           C/A                 0.96(0.81,1.13)      0.592                      0.93(0.79,1.11)   0.430   1.01(0.86,1.18)   0.921   1.03(0.88,1.22)   0.707
                              rs1535500    6     KCNK16           T/G                 0.93(0.80,1.09)      0.390                      0.91(0.77,1.07)   0.239   1.06(0.91,1.23)   0.492   1.06(0.90,1.24)   0.486
                              rs9470794    6     ZFAND3           C/T                 0.97(0.82,1.14)      0.691                      1.00(0.84,1.19)   0.973   1.10(0.93,1.29)   0.256   1.08(0.92,1.28)   0.343
                              rs2191349    7     DGKB, TMEM195    T/G                 1.07(0.91,1.25)      0.419                      1.04(0.88,1.23)   0.648   0.93(0.79,1.08)   0.329   0.91(0.77,1.06)   0.225
                              rs4607517    7     GCK              A/G                 1.09(0.91,1.31)      0.354                      1.06(0.87,1.29)   0.550   0.96(0.79,1.15)   0.629   0.97(0.81,1.18)   0.783
                              rs864745     7     JAZF1            T/C                 1.03(0.85,1.24)      0.783                      1.01(0.82,1.23)   0.951   0.92(0.76,1.11)   0.367   0.95(0.79,1.15)   0.600
                              rs972283     7     KLF14            G/A                 0.92(0.77,1.09)      0.332                      0.93(0.77,1.12)   0.449   0.99(0.84,1.18)   0.928   1.00(0.84,1.19)   0.969
                              rs13266634   8     SLC30A8          C/T                 1.07(0.91,1.25)      0.424                      1.07(0.90,1.28)   0.416   1.11(0.95,1.30)   0.196   1.12(0.95,1.32)   0.164
                              rs516946     8     ANK1             C/T                 1.15(0.90,1.48)      0.271                      1.27(0.97,1.65)   0.083   1.42(1.10,1.83)   0.008   1.39(1.07,1.81)   0.014
                              rs896854     8     TP53INP1         T/C                 0.95(0.81,1.12)      0.560                      0.96(0.81,1.15)   0.683   0.99(0.84,1.16)   0.889   0.96(0.81,1.14)   0.639
                              rs10811661   9     CDKN2A, CDKN2B   T/C                 1.06(0.90,1.25)      0.500                      1.10(0.93,1.31)   0.268   1.14(0.96,1.34)   0.131   1.15(0.97,1.36)   0.110
                              rs17584499   9     PTPRD            T/C                 1.10(0.86,1.41)      0.458                      1.12(0.85,1.46)   0.427   0.90(0.70,1.17)   0.429   0.89(0.69,1.16)   0.404
                              rs2796441    9     TLE1             G/A                 0.91(0.78,1.06)      0.231                      0.93(0.79,1.10)   0.387   1.03(0.88,1.21)   0.691   1.03(0.88,1.21)   0.680
                              rs7041847    9     GLIS3            A/G                 0.95(0.81,1.11)      0.526                      0.98(0.83,1.16)   0.812   0.96(0.82,1.13)   0.627   0.93(0.80,1.10)   0.400
                              rs10886471   10    GRK5             C/T                 1.03(0.85,1.25)      0.748                      1.07(0.87,1.31)   0.538   1.17(0.96,1.42)   0.118   1.20(0.99,1.47)   0.068
                              rs10906115   10    CDC123, CAMK1D   A/G                 0.91(0.77,1.07)      0.262                      0.97(0.81,1.16)   0.747   1.13(0.96,1.33)   0.139   1.10(0.93,1.30)   0.260
                              rs11257655   10    CDC123           T/C                 0.90(0.77,1.06)      0.194                      0.95(0.80,1.13)   0.538   1.12(0.96,1.31)   0.159   1.08(0.92,1.27)   0.366
                              rs5015480    10    HHEX             C/T                 1.18(0.96,1.44)      0.111                      1.24(1.00,1.53)   0.054   0.90(0.73,1.10)   0.305   0.86(0.69,1.06)   0.161
                              rs10830963   11    MTNR1B           G/C                 0.99(0.84,1.16)      0.876                      1.06(0.89,1.25)   0.524   1.09(0.93,1.27)   0.304   1.08(0.92,1.27)   0.371
                              rs1552224    11    CENTD2           A/C                 0.75(0.58,0.98)      0.037                      0.77(0.58,1.01)   0.063   1.39(1.03,1.86)   0.030   1.47(1.09,1.99)   0.013
                              rs2237892    11    KCNQ1            C/T                 0.97(0.82,1.15)      0.719                      0.97(0.81,1.16)   0.721   1.10(0.92,1.30)   0.300   1.12(0.94,1.34)   0.207
                              rs5215       11    KCNJ11           C/T                 0.93(0.79,1.09)      0.362                      0.90(0.76,1.07)   0.225   1.13(0.97,1.33)   0.123   1.15(0.97,1.35)   0.100
                              rs10842994   12    KLHDC5           C/T                 1.09(0.89,1.34)      0.386                      1.12(0.91,1.39)   0.293   0.95(0.78,1.15)   0.577   0.95(0.77,1.16)   0.606
                              rs7961581    12    TSPAN8, LGR5     C/T                 0.86(0.71,1.05)      0.137                      0.88(0.71,1.08)   0.208   1.25(1.04,1.50)   0.020   1.25(1.03,1.51)   0.022
                              rs11634397   15    ZFAND6           G/A                 1.04(0.81,1.34)      0.742                      1.10(0.84,1.44)   0.488   0.89(0.68,1.15)   0.365   0.87(0.67,1.13)   0.287
                              rs2028299    15    AP3S2            C/A                 1.07(0.89,1.29)      0.472                      1.09(0.90,1.32)   0.391   1.19(0.99,1.42)   0.065   1.17(0.97,1.41)   0.100
                              rs7172432    15    C2CD4A, C2CD4B   A/G                 1.16(0.98,1.36)      0.082                      1.13(0.95,1.35)   0.156   1.15(0.98,1.35)   0.092   1.12(0.95,1.33)   0.166
                              rs7178572    15    HMG20A           G/A                 1.06(0.90,1.25)      0.480                      1.09(0.92,1.30)   0.331   1.11(0.94,1.30)   0.219   1.09(0.92,1.28)   0.337
                              rs7403531    15    RASGRP1          T/C                 1.32(1.12,1.56)      0.001                      1.35(1.13,1.62)   0.001   0.95(0.81,1.13)   0.565   0.93(0.78,1.10)   0.373
                              rs1558902    16    FTO              A/T                 1.09(0.87,1.38)      0.454                      1.05(0.82,1.34)   0.72    1.08(0.86,1.36)   0.507   1.08(0.86,1.37)   0.504
                              rs7202877    16    BCAR1            T/G                 0.93(0.76,1.13)      0.443                      0.93(0.75,1.15)   0.505   0.88(0.72,1.07)   0.184   0.89(0.73,1.08)   0.231
                              rs8050136    16    FTO              A/C                 1.08(0.85,1.36)      0.535                      1.03(0.80,1.33)   0.805   1.09(0.86,1.37)   0.484   1.08(0.85,1.37)   0.525
                              rs4430796    17    HNF1B            G/A                 0.99(0.83,1.17)      0.884                      0.96(0.80,1.16)   0.676   0.98(0.83,1.16)   0.824   0.98(0.82,1.17)   0.825
                              rs12454712   18    BCL2             T/C                 1.02(0.87,1.19)      0.852                      1.00(0.85,1.18)   0.966   1.00(0.86,1.17)   0.997   0.98(0.84,1.15)   0.815
                              rs12970134   18    MC4R             G/A                 0.93(0.76,1.15)      0.510                      0.95(0.76,1.19)   0.656   1.10(0.89,1.36)   0.365   1.11(0.89,1.37)   0.355
                              rs8090011    18    LAMA1            G/C                 0.92(0.77,1.09)      0.339                      0.94(0.78,1.13)   0.476   1.10(0.93,1.32)   0.276   1.11(0.93,1.33)   0.249
                              rs10401969   19    CILP2            C/T                 1.03(0.79,1.36)      0.826                      1.00(0.74,1.33)   0.977   0.99(0.75,1.30)   0.937   0.98(0.74,1.30)   0.907
                              rs3794991    19    GATAD2A          T/C                 1.14(0.84,1.56)      0.392                      1.12(0.80,1.56)   0.510   0.87(0.63,1.20)   0.392   0.86(0.61,1.20)   0.362
  **Birth weight**            rs724577     4     LCORL            C/A                 0.98(0.83,1.15)      0.764                      1.04(0.88,1.25)   0.632   1.06(0.90,1.25)   0.486   1.03(0.87,1.21)   0.758
                              rs4432842    5     5q11.2           T/C                 1.17(1.00,1.37)      0.050                      1.23(1.04,1.45)   0.017   1.03(0.88,1.21)   0.701   1.04(0.89,1.22)   0.609
                              rs6931514    6     CDKAL1           G/A                 1.00(0.85,1.19)      0.976                      1.01(0.85,1.21)   0.882   0.93(0.79,1.10)   0.390   0.95(0.80,1.13)   0.562
                              rs1042725    12    HMGA2            T/C                 1.00(0.83,1.22)      0.989                      0.98(0.8,1.21)    0.864   0.98(0.81,1.19)   0.840   0.96(0.79,1.17)   0.716
  **BMI**                     rs2568958    1     1p31             A/G                 1.08(0.82,1.43)      0.582                      1.10(0.81,1.49)   0.545   0.86(0.66,1.13)   0.276   0.85(0.64,1.11)   0.233
                              rs574367     1     SEC16B           G/T                 1.25(1.02,1.53)      0.033                      1.34(1.07,1.67)   0.010   1.01(0.83,1.23)   0.925   1.01(0.83,1.24)   0.893
                              rs7561317    2     TMEM18           G/A                 0.95(0.73,1.24)      0.725                      0.98(0.74,1.3)    0.898   1.07(0.81,1.39)   0.645   1.11(0.84,1.46)   0.468
                              rs16892496   8     TRHR             C/A                 0.98(0.84,1.14)      0.783                      1.00(0.85,1.18)   0.968   0.91(0.78,1.06)   0.224   0.90(0.77,1.05)   0.179
                              rs7832552    8     TRHR             T/C                 0.96(0.82,1.12)      0.585                      0.98(0.83,1.15)   0.782   0.90(0.78,1.05)   0.193   0.89(0.76,1.04)   0.142
                              rs11030104   11    BDNF, BDNF-AS    A/G                 1.18(1.01,1.39)      0.041                      1.12(0.95,1.33)   0.184   0.96(0.82,1.12)   0.582   0.95(0.81,1.11)   0.515
                              rs6265       11    BDNF, BDNF-AS    C/T                 1.14(0.97,1.34)      0.108                      1.10(0.93,1.31)   0.263   0.95(0.81,1.11)   0.524   0.94(0.80,1.11)   0.467
                              rs9939609    16    FTO              A/T                 1.02(0.81,1.30)      0.846                      0.97(0.75,1.25)   0.803   1.06(0.84,1.35)   0.612   1.06(0.83,1.35)   0.641

Model 1 was logistic regression model to analyze the association between individual SNP and quantitative traits without adjusting covariates. Model 2 was logistic regression model to analyses the association between individual SNP and quantitative traits with adjusting continuous covariates, BMI, waist circumference, and sedentary time, and categorical covariates, gender, economical status, education levels, exercise, whole cereal and beans intake levels, livestock and poultry intake levels, drinking, and smoking.

[^1]: Joint first authors, contributed equally.
